|  Corporate ProfileInvestor Hotline: 877-5676-CRL
Accelerating Drug Development. Exactly. Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our approximately 8,000 employees worldwide are focused on providing clients with exactly what they need to improve and expedite the discovery, development through first-in-human evaluation, and safe manufacture of new therapies for the patients who need them.
 |
News Releases
| Date | Title | | | 11/03/09 | Charles River Announces Third-Quarter 2009 Results|
Downloadable version.
Sales Decrease 13.1% to $297 Million
GAAP Earnings per Share of $0.57
and Non-GAAP Earnings
per Share of $0.65
Cost-Reduction Initiatives Now Expected to Total
$40.0
Million of Savings in 2009
Reduces Sales and EPS Guidance for 2009
WILMINGTON, Mass.--(BUSINESS WIRE)--Nov. 3, 2009--
Charles River Laboratories International, Inc. (NYSE: CRL) today
reported its resu... |
|  | | 10/07/09 | Charles River Shanghai Facility Receives AAALAC, CCAC and SLAC Accreditations|
Leading contract research organization achieves regulatory milestones
WILMINGTON, Mass.--(BUSINESS WIRE)--Oct. 7, 2009--
Charles River Laboratories, Inc. (NYSE: CRL), today announced the
Company’s new Shanghai facility received accreditation from the
Association for Assessment and Accreditation of Laboratory Animal Care
(AAALAC), the Canadian Council on Animal Care (CCAC) and the Shanghai
Laboratory Animal Commission (SLAC). The AAALAC, CCAC ... |
| | | 10/06/09 | Charles River Schedules Third-Quarter 2009 Earnings Release and Conference Call| WILMINGTON, Mass.--(BUSINESS WIRE)--Oct. 6, 2009--
Charles River Laboratories International, Inc. (NYSE: CRL) will release
third-quarter 2009 financial results on Tuesday, November 3rd,
after the market closes. A conference call has been scheduled to discuss
the results on Wednesday, November 4th, at 8:30 a.m. ET.
Investors will have the opportunity to listen to a live webcast of the
conference call through the Investor Relations section of t... |
| | | 09/14/09 | Charles River to Present at September Conferences| WILMINGTON, Mass.--(BUSINESS WIRE)--Sep. 14, 2009--
Charles River Laboratories International, Inc. (NYSE: CRL) announced
today that it will present at the Morgan Stanley Global Health Care
Conference in New York on Tuesday, September 15th, at 10:20 a.m. ET and
the UBS Global Life Sciences Conference in New York on Tuesday,
September 22nd at 2:00 p.m. ET. Management will present an
overview of Charles River’s strategic focus and business developments.... |
| |
|
|
Upcoming Events| There are currently no events scheduled. |
| |
